Lobbying by Abbott Laboratories Co.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
In-house (corporation)In effect since Sep 16, 2026
Filed by Luz Herrera, General Manager - Canada, Abbott Diabetes Care
Lobbyists
Andrew Bowles · Director – Government Affairs, Canada
Katie Fretz · Manager, Stakeholder Relations
Luz Herrera · General Manager - Canada, Abbott Diabetes Care
Maria Karounis · General Manager - Canada, Abbott Nutrition
Sophia Shin · Manager, Market Access
Institutions they may lobby: Agriculture and Agri-Food Canada (AAFC), CUSMA Secretariat, Correctional Service of Canada (CSC), Environment and Climate Change Canada (ECCC), Finance Canada (FIN), Global Affairs Canada (GAC), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Intergovernmental Affairs Secretariat (IGA), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Senate of Canada, Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC)
What they're lobbying on (4)Hide details
Engaging with the government regarding Canada's Biomanufacturing and Life Sciences Strategy and artificial intelligence strategy in relation to healthcare.
Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.
Working with Food, Health & Consumer Products (FHCP) Infant Formula Council on the proposed regulatory modernization of Food & Drug Regulations Divisions 24 & 25.
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Engaging with the government regarding Canada's Biomanufacturing and Life Sciences Strategy and artificial intelligence strategy in relation to healthcare.
Victoria Perak · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Engaging with the government regarding Canada's Biomanufacturing and Life Sciences Strategy and artificial intelligence strategy in relation to healthcare.
Niloo Boroun · Director of International Policy, Finance Canada (FIN)
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.
Kabisan Thanendran · Policy Advisor, Public Services and Procurement Canada (PSPC)
Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.
Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.
Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.
Lisa Xie · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.
John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
Jessica Fullerton · Director of Policy to the Minister of International Trade, Global Affairs Canada (GAC)
Engaging government with respect to the importance of the Canada/US/Mexico Free Trade Agreement (CUSMA) to the life sciences sector & ensuring open supply chains to trade partners and tariff-free access to medical devices.Read more
Justine Frame · Senior Policy Advisor, Health Canada (HC)
Engaging government with respect to the importance of CUSMA to the life sciences sector.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.
John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products and Abbott's rapid diagnostic systems.Read more
John Ivison · Administrative Officer, Correctional Service of Canada (CSC)
Bassem Guirguis · National Pharmacist, Correctional Service of Canada (CSC)
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products.Read more
Engaging with the Office of the Minister of Indigenous Services, Office of the Minister of Finance, Office of the Minister of Health, and Members of Parliament regarding the public reimbursement of Abbott brand products.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.